Nov 30, 2021
Greg Gerdeman’s Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as so-called “retrograde messengers” in the brain, which has become a foundation to modern understanding of the ECS and the effects of cannabis. After multiple roles in the...
Nov 24, 2021
It’s an evolution that couldn’t come soon enough! It was 1992 when Valerie Leveroni Corral was first raided by the police, then again in 2002 by the DEA. She never gave up and went on to sue the federal government, eventually winning an injunction against the DEA & DOJ. After nearly 30 years in cannabis, Valerie...
Nov 16, 2021
Psychedelics & Cannabinoids are going mainstream while synthetic designer drugs still flood the market as federal legality lacks to catch up. Dr. Samuel Banister’s (CSO at Psylo) research work has spanned all of these categories. We discuss his past cannabis research, work on synthetic designer drugs and his new...
Nov 9, 2021
Kevin Spelman, PhD, has decades of experience in nutraceuticals, phytonutrients and cannabinoids while filling CSO and VP of R&D roles in laboratory and clinical research. We discuss the unknown parts of the cannabis plant, targeting specific ailments and combining other plant medicines with cannabis for next...
Nov 3, 2021
(1-on-1 Consulting Call) Rachael worked at dispensaries for a few years, then launched her own cannabis coaching business. She recently found a new niche, a secret shopper program for dispensaries. Combining her previous retail experience from big box stores, we discuss how she could package, pitch and deliver her...